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Abstract
In biometric practice, researchers often apply a large number of different methods
in a ”trial-and-error” strategy to get as much as possible out of their data and, due to
publication pressure or pressure from the consulting customer, present only the most
favorable results. This strategy may induce a substantial optimistic bias in prediction
error estimation, which is quantitatively assessed in the present manuscript. The focus
of our work is on class prediction based on high-dimensional data (e.g. microarray
data), since such analyses are particularly exposed to this kind of bias.
In our study we consider a total of 124 variants of classifiers (possibly including
variable selection or tuning steps) within a cross-validation evaluation scheme. The
classifiers are applied to original and modified real microarray data sets, some of which
are obtained by randomly permuting the class labels to mimic non-informative predic-
tors while preserving their correlation structure. We then assess the minimal misclassi-
fication rate over the different variants of classifiers in order to quantify the bias arising
when the optimal classifier is selected a posteriori in a data-driven manner. The bias
resulting from the parameter tuning (including gene selection parameters as a special
case) and the bias resulting from the choice of the classification method are examined
both separately and jointly.
We conclude that the strategy to present only the optimal result is not acceptable,
and suggest alternative approaches for properly reporting classification accuracy.
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1 Background
It is well-known that almost all published studies present positive research results, as outlined
by Kyzas et al [1] for the special case of prostate cancer. In the case of microarray studies,
that often focus on the identification of differentially expressed genes or the construction of
outcome prediction rules, this means that almost all studies report at least a few significant
differentially expressed genes or a small prediction error, respectively.
According to Ioannidis [2], ” [...] most published research findings are wrong”. This may
be partly due to the editorial policy of many journals which accept almost only papers pre-
senting positive research results (except perhaps the recently initiated Journal of Negative
Research Results in Medicine). Authors are thus virtually urged to ”find something signif-
icant” in their data, which encourages the publication of wrong research findings due to a
variety of technical and statistical pitfalls. Microarray studies are especially subject to such
mechanisms and known to yield ”noise discovery” [3].
Technical challenges that particularly affect microarray studies include, e.g. technical
errors in the lab, problems with image analysis and normalization. Statistical pitfalls and
biases of studies on microarray-based prediction are equally diverse. A problem well covered
in the literature is the ”small n large p” dimensionality problem (also referred to as ”n p”,
i.e. less observations than variables). In univariate analyses for identifying differentially
expressed genes, the multiple testing problem resulting from high dimensionality can be
addressed, e.g. by means of approaches based on the false discovery rate [4, 5].
In the context of microarray-based prediction, another important statistical pitfall is
incomplete cross-validation (CV), as pointed out by numerous authors [6–10]: if the selection
of relevant variables is performed before cross-validation using all available observations,
the cross-validated error rate is quite naturally optimistically biased. Most recent studies
take this important point into account, either by performing variable selection for each CV
iteration successively or by using class prediction methods involving an intrinsic variable
selection step, like the Lasso [11]. Hence, we do not address again the problem of incomplete
CV in the present article.
The reported classification error rate can also be lowered artificially by selecting the values
of tuning parameters a posteriori, i.e. on the basis of the computed CV error rate. Doing
this, one selects the ”best” version of a classifier and evaluates it using the same data, which
of course leads to an underestimation of the error rate (named ”bias source I” in our present
paper). A quantitative study on this topic can be found in [12]. Note that the problem of
optimal parameter selection affects not only microarray but also classical medical studies
based on conventional low-dimensional predictors, although probably not as dramatically.
A particular parameter that is especially crucial in the analysis of high-dimensional data is
the number of selected variables (if variable selection is performed). In many studies, it is
chosen a posteriori based on the CV results, thus inducing biases in the reported error rate.
Another source of bias (named ”bias source II” in our paper) that is related to, but more
global than optimal parameter selection, is the optimal selection of the classification method
itself from the wide range of classifiers that are available for the analysis of microarray data
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today (e.g. support vector machines, random forest or L2 penalized logistic regression). This
again is an issue that, in principle, can be encountered in all types of medical studies, but
affects microarray studies more drastically. Whereas standard statistical approaches – for
instance logistic regression for class prediction problems – have become the methodological
”gold standard” in conventional medical statistics and allow a comparatively fair evaluation
of research results, the field of microarray data analysis is characterized by the lack of
benchmark standard procedures and a huge and heterogeneous amount of methods – ranging
from adaptations of standard statistical procedures to computerintensive approaches adopted
from machine learning – whose respective merits and pitfalls remain partly unexplored. This
is particularly true for studies involving class prediction problems, i.e. when the goal is to
derive a classification rule for predicting the class membership (typically the disease outcome)
of patients based on their microarray transcriptome data.
In this context, it is common practice to evaluate the performance of classifiers based on
techniques like cross-validation (CV) including leave-one-out cross-validation (LOOCV) as a
special case, repeated splitting into learning and test data sets, or bootstrap sampling. See
the methods section for more details on the cross-validation technique used here and [13] for
an extensive review on cross-validation and resampling techniques in general.
However, it is not sufficient to use correct methods together with a correct internal cross-
validation scheme [14]: let us consider the case where cross-validation (or a similar approach
such as bootstrap sampling or repeated subsampling) is used because the sample is not large
enough to put aside a validation data set, or in order to select the model to be tested on
the validation data set. Trying several classification methods and then reporting only the
results obtained with the classifier yielding the smallest error rate is an incorrect approach,
because it induces an optimistic bias.
In this article, we report the results of an experiment that allows us to quantify the
optimistic bias induced by optimal tuning parameter selection (bias source I) and optimal
selection of the classification method (bias source II) in a realistic setting based on original
microarray data. After we have illustrated the drastic effect of optimal classifier selection,
we discuss alternative ways to report results of class prediction studies when no validation
set is available, and give suggestions for good scientific practice in this context.
In our experiment we compute the misclassification rate of a total of 10 usual clas-
sification methods (k-nearest-neighbors, linear discriminant analysis, Fisher’s discriminant
analysis, diagonal linear discriminant analysis, partial least squares followed by linear dis-
criminant analysis, neural networks, random forests, support vector machines, shrunken
centroid discriminant analysis and ridge regression) based on cross-validation. Some of these
10 classification algorithms are combined with preliminary variable selection or/and used
with different plausible tuning parameter values successively. The aim is to investigate the
different sources of biases resulting from optimal selection (optimal choice of tuning param-
eters including gene selection and optimal choice of the classification method) and their
relative importance. All the considered procedures are classical approaches, most of which
have already been used in published medical studies. For the sake of reproducibility, all
our analyses are based on the freely available Bioconductor package CMA version 0.8.5 [15]
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which is described extensively in [16].
The classifiers are applied to original and modified data sets, some of which are obtained
by permuting the class labels of real microarray data sets. We then assess the minimal
misclassification rate over the results of the different variants of classifiers in order to quantify
the bias arising when the optimal classification method and/or its tuning parameters are
selected a posteriori in a data-driven manner. The permutation of the class labels is used
to mimic data sets under the global null hypothesis that none of the genes are differentially
expressed with respect to the response class. This approach thus provides non-informative
microarray data that, however, preserve their realistic correlation structure, and can serve
as a ”baseline” to quantify the bias induced by optimal classifier selection.
Another aspect relevant in clinical practice is that a prediction tool should always be
thoroughly evaluated based on fresh external validation data [17, 18]. This problem goes
beyond the scope of this paper, which focuses on the developmental phase involving a CV-
like procedure. However, both issues are tightly connected, since it would be a waste of
time and money to start the validation phase if the results of the developmental phase are
over-optimistic due to an incorrect analysis.
2 Methods
2.1 Generating the data
Three types of data sets are used in the present study: i) non-modified real data sets, ii) data
sets with permuted class labels, to mimic non-informative microarray data with a realistic
correlation structure, and iii) subsamples of non-modified real data sets including 60, 65, 70,
75, 80, 85, 90 or 95% of the original sample, to be able to evaluate potential effects of the
sample size. To average out the random fluctuations due to the permutation process, we
consider niter = 20 balanced permutations successively. The term ”balanced” permutation
here means that within each true class, a fraction of about N1/N of the observations are
randomly assigned to class 1, and a fraction of N0/N of the observations to class 0, where
N0 and N1 denote the numbers of observations from classes 0 and 1 respectively in the entire
sample. By doing so, we make sure that none of the permuted class label vectors is similar
to the true class label vector by chance.
Two real-life data sets are considered successively: the well-known benchmark colon data
set [19], and the prostate cancer data set [20].
2.2 Included classifiers
This study includes only well-known classifiers that are widely used in the context of class
prediction in medical studies and yield acceptable accuracies in ”neutral comparison studies”
(see [13] for criteria defining such studies). For instance, methods like quadratic discriminant
analysis are excluded because they seem to perform poorly [21] and are not often used in
practice.
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We consider a total of 124 classifiers. By classifier, we mean the combination of the
variable selection procedure (if any) and the method used to construct the prediction rule,
potentially including different tuning parameter settings. More specifically, we use the ten
classification methods outlined below:
• KNN (k-nearest-neighbors): the standard nearest-neighbor approach [22]. We con-
sider successively k=1, 3, 5, which are all usual choices when the method is used on
small sample data.
• LDA (Linear Discriminant Analysis): standard linear discriminant analysis with nor-
mality assumption and common within-group covariance matrix, as summarized in
[21,22].
• FDA (Fisher’s Discriminant Analysis): standard Fisher’s discriminant analysis [21].
• DLDA (Diagonal Linear Discriminant Analysis): the same as LDA, except that the
common within-group covariance matrix is assumed to be diagonal. The feature makes
it applicable to data with n p.
• PLSLDA: Partial Least Squares (PLS) dimension reduction (see [23] for an overview)
followed by linear discriminant analysis using the PLS components as predictors [24].
We set the number of PLS components to ncomp = 2 and ncomp = 3 successively.
• NNET: neural networks with one hidden layer.
• RF (Random Forests): the random forest method [25] aggregating a large number
of classification trees obtained from different subsamples and with random selection
of candidate predictors at each split. The number of trees is set to ntree = 1000,
whereas the number mtry of candidate predictors considered at each split is set either
to mtry =
√
p (default setting for classification), 2
√
p, 3
√
p or 4
√
p, which are all
sensible values [26].
• SVM (Support Vector Machines): the well-known kernel method by Vapnik [27].
Tuning parameters include the kernel function (for instance linear and radial), the
cost (for both linear and radial kernels) and the parameter controlling the width of
the radial kernel. In this paper, we consider linear kernels only (the default in the R
function svm from the e1071 package), which are known to perform well. The cost is
considered as a tuning parameter and optimized via internal 3-fold-cross-validation.
• PAM (Shrunken Centroid Discriminant Analysis, also called ”Prediction Analysis with
Microarrays”): the nearest shrunken centroids method [28]. The shrinkage parameter
is optimized via internal 3-fold-cross-validation.
• L2: the L2-penalized logistic regression approach (also called ridge regression). In
contrast to Lasso, this approach does not yield sparse models. The penalty parameter
is optimized via internal 3-fold-cross-validation.
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The methods used to construct prediction rules are summarized in Table 1 together with
the different numbers of genes and parameter values considered in this study. All the methods
are well-known and reported to perform reasonably well in the literature. Note that we could
also have included methods like the Lasso [11] and elastic net [29]. However, we do not
consider them in the present study because they show convergence problems in some cases.
Other methods which could have been included are tree-based and componentwise boosting
[30], or alternative dimension reduction techniques (see [31] for a synthetic overview). We
only include a limited number of methods to keep the scope of the study manageable, but
also to mimic the scope of methods that an average biostatistician/bioinformatician would
realistically be able to apply to his/her data in a limited time-frame. Some arbitrariness in
the choice of the methods is unavoidable, but we feel that the current selection covers the
spectrum of methods currently available and attractive for microarray studies reasonably
well. In particular, it includes both purely statistical approaches and machine learning
algorithms.
2.3 Tuning parameters
One of the two sources of bias investigated in this paper is the optimal selection of tuning
parameters including as a special case the number of selected genes and the gene selection
method - if preliminary variable selection is performed.
2.3.1 Preliminary variable selection
Regarding variable selection, classification methods can be divided into several categories:
1. Methods that do not take each variable’s prediction strength into account, such as k-
nearest-neighbors. Such methods almost always yield poor prediction accuracies when
applied to noisy data. For instance, in the nearest neighbors approach, array-to-array
distances on which prediction is based are computed using all genes irrespectively of
their discrimination power. Such methods should be combined with variable selection.
2. Methods that take the variables’ prediction strength into account, but can technically
not be applied to data with n p, like linear discriminant analysis. For such methods
to be applicable, previous variable selection is necessary and the number of selected
variables should be smaller than the number of observations.
3. Methods that take the variables’ prediction strength into account and can technically
be applied to data with n  p, but usually perform better on a reduced subset of
relevant genes, like diagonal linear discriminant analysis (DLDA). By definition, DLDA
gives more weight to genes with a high signal-to-noise ratio. However, genes with poor
or no discriminating power behave as noise and usually decrease classification accuracy
substantially.
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4. Methods that take the variables’ prediction strength into account can technically be
applied to data with n  p and whose prediction accuracy is usually not improved
by preliminary variable selection. Such methods include, e.g. nearest shrunken cen-
troids or the Lasso, that perform variable selection intrinsically. Note, however, that
preliminary variable selection may be necessary in some cases in practice for computa-
tional reasons, especially when the number of genes reaches several tens of thousands
as common in modern data sets.
In the present study, we consider only smaller data sets with p < 10, 000 genes, which
makes preliminary variable selection for the retained methods of type 4 unnecessary from
a computational point of view. For methods of types 1 to 3, previous variable selection is
applied with different (round) numbers of genes p∗: 10 and 20 genes when the method requires
n > p∗ and 20, 50, 100, 200, or 500 genes when the method can cope with n < p∗, see Table
1 for an overview. In our study, three very common selection criteria are used successively:
the absolute value of the two-sample t-statistic, the absolute value of the limma statistic [32]
and the absolute value of the normalized two-sample Wilcoxon statistic. Note that further
methods could have been considered, such as the ”traditional” Golub criterion or more
sophisticated multivariate approaches, e.g. based on random forests [26]. In our experiment,
however, we focus on the most standard approaches, because we consider it realistic that
a statistician, who wants to try a large number of procedures, would prefer those that are
freely available or easy to implement, computationally efficient and conceptually simple.
2.3.2 Other tuning parameters
Apart from preliminary variable selection, some of the considered classification methods
involve tuning parameters, for instance the shrinkage parameter of the PAM method, the
penalty in L2 penalized regression, and the cost parameter in linear SVM. In our study,
these method parameters are tuned by performing an internal 3-fold-cross-validation using
the learning set only, because i) it is a commonly recommended strategy [33], and ii) there
is no reliable ”gold standard” for these parameters.
We also consider classification methods involving tuning parameters for which default
values are expected to work reasonably well with most data sets. In this case, parameter
tuning through inner cross-validation is not as essential and well-established as for methods
like penalized regression. In our study, these methods include KNN (with the number k
of neighbors as parameter), random forests (with the number mtry of candidate splitting
variables considered at each split as parameter), and PLSLDA (with the number ncomp
of PLS components as parameter). For these three methods, we consider a few standard
values of the tuning parameter successively and investigate the bias resulting from optimal
selection, see Table 1 for an overview. Some subjectivity and arbitrariness in the study
design is unavoidable, but this setup can give a realistic example of the bias that is induced
when certain choices in model selection are based on optimizing performance on the learning
data.
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2.3.3 The 124 variants of classifiers
On the whole, we obtain 124 variants of classifiers from the combination of 10 classification
methods, some in combination with different numbers p∗ of preselected genes, each selected
with one of three selection criteria (t, limma or Wilcoxon statistic), and different tuning
parameter settings. The number 124 is obtained as
max(G× 3, 1)×max(T, 1),
where G is the number of values of p∗ (i.e. the number of values in the third column of Table
1 with the convention G = 0 when no gene selection is performed), three is the number
of considered gene selection methods (t-statistic, Wilcoxon, limma), and T is the number
of considered values for the fixed tuning parameters (i.e. the number of values in the fifth
column of Table 1 with the convention T = 0 if there are no such fixed parameters). This
formula yields:
KNN: 5 values of p∗ × 3 gene selection criteria × 3 values of k +
LDA: 2 values of p∗ × 3 gene selection criteria +
FDA: 2 values of p∗ × 3 gene selection criteria +
DLDA 5 values of p∗ × 3 gene selection criteria +
PLSLDA: 5 values of p∗ × 3 gene selection criteria × 2 values of ncomp +
NNET: 5 values of p∗ × 3 gene selection criteria +
RF: × 4 values of mtry +
SVM: +
PAM: +
L2: =
124 classifiers.
A detailed list of the numbers of preselected genes and tuning parameter settings is given
in Table 1.
2.4 Cross-validation (CV)
It is well-known that the prediction accuracy of a classifier should not be evaluated based
on the data that were used for its construction. Instead, if no independent validation set is
available, the classifier should be evaluated through a CV-like technique considering several
pairs of learning and test sets successively.
In the present experiment, we use one of the most widely used evaluation schemes: k-fold
cross-validation. In k-fold cross-validation (for instance k = 5), the available data set is split
in k approximately equally sized subsets. At each of the k iterations, one of these subsets is
considered as a test data set, while the union of the k − 1 other subsets forms the learning
set. The cross-validated error rate is then computed by averaging the error rates obtained
in all k iterations. The reader is referred to [13, 34] for more technical details and critical
discussions of cross-validation or related evaluation procedures. In the present study, the
number k of iterations is set to the standard value k = 5.
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2.5 Implementation
In this study, we use the Bioconductor package ’CMA’ [15] described in [16].
3 Results
3.1 Data sets and real data analysis results
We first analyze the well-known colon cancer microarray data set [19] including p = 2000
genes for 22 normal and 40 tumor tissues (n = 62) that is available from the Bioconductor
package ’colonCA’. This data set was analyzed in numerous classification-based articles in-
cluding comparison studies [35]. The obtained error rates usually range between 10% and
20%. Note that the results from different studies are difficult to compare, since they are
all based on different evaluation designs (for instance CV, LOOCV, bootstrap, etc.) and
different variable selection approaches.
We apply the 124 classifiers to this data set and obtain error rates ranging from 13% to
> 40%, see Table 2 (top) for the results obtained without preliminary variable selection (for
RF, SVM, PAM, L2) or with variable selection based on the t-statistic (for KNN, LDA, FDA,
DLDA, PLSLDA, NNET). The results with the Wilcoxon statistic and the limma statistic
are similar. As can be seen from Table 2, the different methods yield noticeably different
results.
The second data set investigated in the present study is introduced by Singh et al [20]
and includes 5908 genes for 50 normal and 52 prostate cancer tissues. We use the data
preparation procedure described in [24]. This data set usually yields better accuracy than
the colon data set, which may be partly due to the larger sample size, see for instance [24].
In the present study, the estimated error rates strongly vary across the classifiers. Whereas
some well-known classifiers such as PAM yield poor accuracy (error rates of approximately
20%), others, such as partial least squares, yield error rates of approximately 6%, see Table
2 (bottom) for a summary.
Note that the relative performance of the different methods is substantially different in
the two data sets. This is consistent with the widely acknowledged fact that there is no
unique ”best” classification method yielding top-performance for all data sets. Hence, it
would be unwise to try only one classification method: the multiplicity issue investigated in
this study is relevant.
3.2 Permutation-based analysis
In this part of the analysis, we simulate non-informative gene expression data sets by per-
muting the class labels of the two data sets described above, thus mimicking non-informative
microarray data with a realistic correlation structure. To average out variations due to the
random permutation, 20 balanced permutations are considered successively. The two sources
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of bias (optimal selection of the tuning parameters and optimal selection of the classification
method) are assessed separately in the two next subsections.
3.2.1 Bias source I: tuning parameters and gene selection
The aim of this part of the analysis is to assess the bias induced by optimally selecting the
number of genes p∗, the gene selection procedure and/or the tuning parameters based on
the CV-results. For each of the 10 classification methods and each of the 20 permuted data
sets, we consider the six following error rates:
Approach A: Minimal error rate over the different tuning parameter values (k =
1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF),
different numbers of genes and different gene selection methods.
Approach B: Minimal error rate over the different numbers of genes and different
gene selection methods. In contrast to A, the tuning parameter is fixed for all methods
involving a tuning parameter other than the number of genes (mtry =
√
p for RF,
ncomp = 2 for PLSLDA, and k = 5 for KNN).
Approach C: Minimal error rate over the different tuning parameter values (k =
1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF) and
different gene selection methods. In contrast to A, the number of genes is fixed (p∗ = 20
for the methods requiring n > p, p∗ = 100 for the other).
Approach D: Minimal error rate over the different tuning parameter values (k =
1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF) and
different numbers of genes. In contrast to A, the gene selection method is fixed (gene
selection based on the t-statistic for all methods involving gene selection).
Approach E: Minimal error rate over the different tuning parameter values (k =
1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF). In
contrast to A, the number of genes and the gene selection method are fixed (gene
selection based on the t-statistic, p∗ = 20 for the methods requiring n > p, p∗ = 100
for the other).
These minimal error rates are computed for all 20 permutation runs and for each of the
10 classification methods. For each classification method and each approach, the median
over the 20 runs is given in Table 3. For comparison, Table 3 also gives the median error
rate calculated from all 124 × 20 error rates obtained with the 124 classifiers for the 20
permutation runs (last column: F). The difference between this baseline and the minimal
error rates A, B, C, D, and E can be interpreted as the bias induced by optimal selection.
It can be seen from Table 3 that, for a given classification method, the optimization of
the gene selection method, of the number of genes and of the tuning parameters contribute
approximately equally to the bias: there is no unique source of bias. Let us consider the
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KNN method applied on the prostate data for illustration. The median minimal error rate
over all parameter values (k = 1, 3, 5), all numbers of genes (p∗ = 20, 50, 100, 200, 500) and
the three gene selection methods (t-statistic, Wilcoxon, limma) is 0.43. It equals 0.45 if
one optimizes over the results obtained with k = 5 only (Approach B) and if one optimizes
over the results obtained with p∗ = 100 only (Approach C). Optimization over the results
obtained with the t-statistic as fixed gene selection method (Approach D) yields a median
error rate of 0.47, while the optimization over the three tuning parameter values yields the
higher value 0.50.
Most importantly, if all 10 classification methods are considered simultaneously, the bias
due to the optimization of the classification method dominates all the other sources of bias,
as investigated in more details in the next section.
3.2.2 Bias source II: choice of the classification method
In this subsection, we consider the second source of bias, namely the optimal choice of the
classification method. Here the tuning parameters are either optimized through a correct
inner cross-validation procedure or fixed to a single plausible value in order to handle all 10
classifiers equally. The minimal error rate is derived over the resulting 10 error rates. The
10 considered combinations are as follows: KNN with k = 5 and p∗ = 100 genes selected
based on the t-statistic, LDA with p∗ = 20 genes selected based on the t-statistic, FDA with
p∗ = 20 genes selected based on the t-statistic, DLDA with p∗ = 100 genes selected based on
the t-statistic, PLSLDA with ncomp = 2 and p∗ = 100 genes selected based on the t-statistic,
NNET with p∗ = 100 genes selected based on the t-statistic, RF with mtry =
√
p, SVM with
cross-validated cost, PAM with cross-validated shrinkage parameter, L2 with cross-validated
penalty. Note that p∗ = 20 genes were used for the methods of type 2 that require n > p.
For each of the 20 permutation runs, the minimal error rate Err
(H0)
min10 over these 10
classifiers is derived, where the exponent (H0) in Err
(H0)
min10 indicates that this error rate was
computed based on permuted data, i.e. under the null-hypothesis of no association between
the response class and the predictors.
Moreover, we also derive the minimal error rate over the 6 × 3 + 4 = 22 classifiers
yielded as combinations of a classification method and a gene selection method (for the six
classification methods KNN, LDA, FDA, DLDA, NNET, with fixed p∗ = 100). The rationale
behind this is that it makes sense to consider the gene selection procedure as a component
of the classification method rather than as a tuning parameter. This minimal error rate is
denoted as Err
(H0)
min22.
The distribution of Err
(H0)
min10 and Err
(H0)
min22 over the 20 permutation runs is displayed in
form of boxplots in Figure 1 for the colon data set (left panel) and the prostate data set
(right panel). For comparison, Figure 1 also shows the boxplot of the minimal error rate
Err
(H0)
min124 obtained by minimizing over all 124 classifiers (left box) and the distribution of
all 124 × 20 = 2480 error rates obtained by running the 124 classifiers on the 20 permuted
data sets (right box).
Additionally, Figure 1 includes three theoretical baseline values corresponding to i) an
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error rate of 50%, ii) the mean error rate 2N0N1/N
2 which would be obtained by randomly
assigning N0 observations to class Y = 0 and N1 observations to class Y = 1 (dotted
line), and iii) the error rate min(N0, N1)/N which would be obtained by assigning all the
observations to the majoritary class (dashed line).
As expected, Figure 1 shows that the global minimal error rate Err
(H0)
min124 over the 124
classifiers is affected by a strong bias compared to the three baselines. A perhaps more
striking result is that Err
(H0)
min10 (obtained by minimizing over the 10 classification methods)
and Err
(H0)
min22 (obtained by minimzing over the 22 combinations of classification methods
and gene selection methods) also carry a substantial bias, especially in the colon data set.
Unsurprisingly, Err
(H0)
min10 and Err
(H0)
min22 are greater than Err
(H0)
min124, because optimization is
performed over 10 and 22 error rates, respectively, instead of 124. However, it is clear from
Figure 1 that a large part of the total bias is due the optimization of the classification
method. If one additionally optimizes the tuning parameters (including the number of genes
as a special case), the bias only increases moderately.
Note that the bias compared to the baseline 50% is higher for the colon data set than
for the prostate data set, which can be at least partly explained by the difference of the
sample sizes and the ratio of class frequencies (almost 1:1 in the prostate data set, but ≈2:1
for the colon data set). More precisely, under the null-hypothesis of non-informative gene
expression data, the median minimal error rate is 31% for the colon data set, and 41% for
the prostate data set.
3.3 Outlook: subsample analysis
As an outlook, the bias over the 124 classifiers is also assessed based on subsamples drawn
randomly from the original data set. We successively consider subsamples corresponding to
60, 65, 70, 75, 80, 85, 90 or 95% of the sample size n. For each proportion of the original
sample size, the procedure is repeated 20 times to average out variability due to random
subsampling. The minimal error rate over the 124 classifiers is derived for each subsample.
Figure 2 represents the boxplots of the minimal error rate Err
(H0)
min124 over the 124 classifiers
for each subsample size (each boxplot corresponds to 20 error rate estimates) for the colon
cancer data [19] and the prostate cancer data [20]. It can be seen that the median minimal
error rate is approximately 12-13% and 5-6% for all subsample sizes for the colon and the
prostate data, respectively, i.e. does not increase with decreasing sample size as usually
expected in prediction. This observation is the result of two competing effects. On the one
hand, the error rate of each single classifier is inversely related to the sample size. On the
other hand, when the sample size decreases, the variance of the 124 estimated error rates
increases, thus decreasing the minimum over the 124 classifiers. On the whole, these two
competing effects seem to approximately compensate, yielding a constant median minimal
error rate for both data sets, as can be observed from Figure 2.
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3.4 Some solutions
From the results presented in the previous section, it is clear that one should definitely not
report only the best result Errmin124, because this strategy generates substantial optimistic
bias. The two investigated sources of bias generate substantially over-optimistic results.
While the bias due to the optimal selection of the tuning parameters can be easily avoided
by systematically using inner cross-validation to choose the tuning parameter values, the bias
due to the optimal selection of the classification method is more difficult to handle. Although
the classification method could theoretically also be considered as a tuning parameter and
optimized through inner cross-validation, this approach would be very difficult to implement
in practice and yield substantial interpretation problems.
In order to avoid such biases in practical studies, we give the following recommendations,
which partly overlap with those given in [14]. First, one should test the derived classifier
on untouched validation data whenever possible. This approach consists of splitting the
available data into i) a training set which is used to construct classifiers and select the ”best”
one and ii) a validation data which is not opened until a final classifier has been selected
based on the training data, in the vein of the validation strategy described by Daumer et
al [36]. In practice, this is possible only when the sample is large enough, say, n ≥ 100,
a condition which is not fulfilled by all microarray studies. When a validation data set is
available, the error rate estimates of the cross-validation procedure on the training set are of
secondary importance. Cross-validation is only used for selecting the best classifier, i.e. for
comparison purposes but not for estimating the error rate. The estimate of the error rate
obtained from the validation data set is then unbiased, since this data set was not opened
during the training phase. Note that the more classifiers are tried during the training phase,
the more the validation accuracy will decrease compared to the best training accuracy, due
to multiple comparisons effects.
If the study does not include any validation step with untouched data, one should
not only report the results obtained with the best performing method/parameter combina-
tion/number of genes, as demonstrated in our study on original and modified real microarray
data. In this situation, reporting the results in a fair way is a complex task. Ideally, the
considered classification methods should be documented in form of an analysis plan (in the
vein of those written by pharmaceutical laboratories for their (pre-)clinical studies) before
starting the data analysis. In this context, the publication of analysis plans on open access
platform like Nature Precedings is to be encouraged [37].
However, analysis plans do not answer the question of how to report results from different
classifiers. Reporting the results of all tried classifiers would be confusing, need too much
space, and unavoidably raise the question of which estimate is the ”right one”. Reporting an
average error rate would be a solution to these problems, but some arbitrariness remains in
the choice of classifiers: by including inappropriate classifiers, one could almost arbitrarily
increase the average error rate. Therefore the intuitive interpretability of an average error
rate would require that the set of candidate classifiers is the same in all studies. Although
some efforts have been made in the last few years to define a set of standard classifiers (see
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for instance the R packages ’MCRestimate’ [38] and ’CMA’ [15]), the standardization of
candidate classifiers in medical research is still in its infancy.
Alternatively, we suggest an approach inspired from our permutation-based simulation
design. Since it does not make sense to focus on bad performing classifiers, we suggest to
consider the minimal error rate over all tried classifiers as the main outcome of the study.
However, to avoid hasty optimistic conclusions, we propose to compare this minimal error
rate from the original data Errmin with the average minimal error rate obtained from data
sets with permuted class labels Err
(H0)
min , as considered as a baseline in our simulation study.
More precisely, we suggest to report the results of microarray studies in the following
form: ”By using microarray predictors, the minimum achievable prediction error for the
colon data set could be reduced from 31% (baseline under H0) to 13%.” This reporting
scheme has two strong advantages: i) it automatically adjusts for the number of candidate
classifiers and ii) it accounts the fact that the error rate also depends on the class proportions.
4 Conclusions
In this article, we have quantitatively assessed the bias induced by reporting only the error
estimate of an optimally selected classifier. The focus here was on the classifier construction
step, which is one of the most complex from a statistical point of view. However, the optimal
choice of a method might take place at other levels of microarray preprocessing and analysis,
too. Firstly, the normalization technique (e.g. MAS, RMA, etc for Affymetrix) can also be
optimized, since there exist a number of normalization approaches which can be tested easily,
for instance using standardized R packages from the Bioconductor platform. The choice of
the normalization procedure may greatly affect the classification accuracy of prediction rule,
perhaps even more than the choice of the classifier. However, each team probably has its
preferred procedure and applies it systematically without switching to another one, even if
the results are disappointing. Hence, the choice of the normalization technique is probably
not a source of optimal selection bias in the sense considered here.
Secondly, one could optimize the criterion used to filter out genes that are, e.g. not
enough regulated. Several variants of selection criteria can be used, such as the fold change
or p-value criteria with various thresholds. For instance, if the results are disappointing
using the genes with fold change > 2 in at least five arrays, the statistician might decide
to be more stringent and select only genes with fold change > 3. These aspects go beyond
the scope of this article, which focus on class prediction. However, they may add additional
bias. On the whole, the bias observed in this study can on one hand be considered as
overestimated (because few statisticians will try all 124 classifiers), but on the other hand
as underestimated (because other potential sources of bias have not been considered).
Of course, the bias outlined in the present article does not only affect biomedical articles,
but also potentially methodological articles, where tuning parameters or method features
are often optimized based on the data set used for evaluation and comparison. We believe
that, as a long term perspective, new learning methods should be developed and tested on
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different data sets following an ”analysis plan”, in the vein of the validation strategy used in
clinical research. The result to be validated would then be the superiority of the new method
over existing methods rather than – as often in clinical studies – the significance of a p-value
or the predictive power of gene expression. Of course, the content of a methodological article
should not be reduced to the effective improvement of accuracy on real data sets. Rather
than that, other aspects of new methods need to be considered, such as theoretical arguments
and properties, conceptual simplicity, ability to generalize and fit in a more global framework
or computational efficiency. Still we claim that, when improvement of accuracy is presented
as the major advantage of a new method, it should be assessed with the same strictness that
we request for medical studies.
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Figures
Figure 1 - Permutation-based analyses
Alon’s colon cancer data (left) and Singh’s prostate cancer data (right). Boxplot of the
minimal error rate over the 124 considered classifiers, for the 20 permutations = 20 points
(left), and of all the error rates obtained with the 124 classifiers for the 20 permutations
= 124× 20 points (right). The three horizontal lines represent the three baseline error rates
defined as follows: the error rate obtained by assigning all observations to the majoritary
class (plain), the error rate obtained by randomly assigning N0 observations to class 0 and
N1 observations to class 1 (dotted), and 50% (dashed). Main conclusion: The minimal
error rate is much lower than all three baseline error rates, and a large part of this bias is
due to the optimal selection of the classification method.
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Figure 2 - Subsample analyses
Alon’s colon cancer data (left) and Singh’s prostate cancer data (right). Boxplots of the
minimal error rate over the 124 classifiers for each subsample size (each boxplot corresponds
to 20 error rate estimates). Main conclusion: The median minimal error rate does not
seem to increase with decreasing sample size.
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Tables
Table 1 - Summary of the considered candidate classifiers
Column 1: Acronym of the method. Column 2: Type of the method regarding preliminary
variable selection. Column 3: Number of selected genes p∗ (if preliminary variable selection
is performed). Column 4: Name of the function in the CMA package. Column 5: Name
and values of the fixed parameters. Column 6: Name of the parameters tuned using internal
3-fold-cross-validation.
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Table 2 - Results of the real data study, colon data
CV error rates obtained with different methods for the colon data set (top) [19] and the
prostate data (bottom) [20], with variable selection (if any) based on the t-statistic.
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Colon p∗ 10 20 50 100 200 500 2000
Method Parameter
KNN k = 1 − 0.21 0.21 0.24 0.18 0.23 −
KNN k = 3 − 0.20 0.15 0.18 0.16 0.16 −
KNN k = 5 − 0.19 0.16 0.19 0.15 0.13 −
LDA 0.19 0.21 − − − − −
FDA 0.18 0.21 − − − − −
DLDA − 0.15 0.16 0.13 0.18 0.22 −
PLSLDA ncomp = 2 − 0.16 0.16 0.16 0.18 0.18 −
ncomp = 3 − 0.19 0.16 0.13 0.16 0.18 −
NNET − 0.35 0.31 0.37 0.32 0.35 −
RF mtry =
√
p − − − − − − 0.19
mtry = 2
√
p − − − − − − 0.18
mtry = 3
√
p − − − − − − 0.16
mtry = 4
√
p − − − − − − 0.18
SVM − − − − − − 0.16
PAM − − − − − − 0.27
L2 − − − − − − 0.15
Prostate p∗ 10 20 50 100 200 500 5908
Method Parameter
KNN k = 1 − 0.17 0.15 0.12 0.11 0.12 −
KNN k = 3 − 0.08 0.11 0.09 0.09 0.11 −
KNN k = 5 − 0.08 0.09 0.10 0.09 0.11 −
LDA 0.06 0.07 − − − − −
FDA 0.06 0.07 − − − − −
DLDA − 0.12 0.12 0.14 0.20 0.24 −
PLSLDA ncomp = 2 − 0.07 0.06 0.06 0.08 0.10 −
ncomp = 3 − 0.05 0.06 0.05 0.07 0.08 −
NNET − 0.14 0.20 0.10 0.10 0.25 −
RF mtry =
√
p − − − − − − 0.09
mtry = 2
√
p − − − − − − 0.07
mtry = 3
√
p − − − − − − 0.07
mtry = 4
√
p − − − − − − 0.07
SVM − − − − − − 0.11
PAM − − − − − − 0.23
L2 − − − − − − 0.08
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Table 3 - Results of the permutation study
Colon data set [19] and the prostate data set [20], with variable selection (if any) based
on the t-statistic. Approach A: Minimal error rate over the different tuning parameter
values (k = 1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for
RF), different numbers of genes and different gene selection methods (median over the 20
runs). Approach B: Minimal error rate over the different numbers of genes and different
gene selection methods (median over the 20 runs). Approach C: Minimal error rate over
the different tuning parameter values (k = 1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA,
mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF) and different gene selection methods (median over the
20 runs). Approach D: Minimal error rate over the different tuning parameter values
(k = 1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA, mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF) and
different numbers of genes (median over the 20 runs). Approach E: Minimal error rate
over the different tuning parameter values (k = 1, 3, 5 for KNN, ncomp = 2, 3 for PLSLDA,
mtry =
√
p, 2
√
p, 3
√
p, 4
√
p for RF) (median over the 20 runs). Approach F: Median of all
124× 20 calculated error rates.
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Colon A B C D E F
KNN 0.34 0.35 0.36 0.38 0.41 0.45
LDA 0.39 − 0.43 0.42 − 0.46
FDA 0.42 − 0.43 0.46 − 0.48
DLDA 0.36 − 0.40 0.42 − 0.43
PLSLDA 0.34 0.34 0.38 0.37 0.42 0.43
NNET 0.34 − 0.35 0.35 − 0.36
RF 0.40 0.40 − − 0.40 0.42
SVM 0.38 − − − − −
PAM 0.37 − − − − −
L2 0.44 − − − − −
All 0.31 0.32 0.33 0.34 0.34 0.43
Prostate A B C D E Baseline
KNN 0.43 0.45 0.45 0.47 0.50 0.52
LDA 0.46 − 0.47 0.50 − 0.51
FDA 0.45 − 0.47 0.49 − 0.49
DLDA 0.46 − 0.49 0.49 − 0.51
PLSLDA 0.44 0.46 0.47 0.49 0.51 0.52
NNET 0.45 − 0.50 0.48 − 0.53
RF 0.52 0.54 − − 0.52 0.54
SVM 0.54 − − − − 0.54
PAM 0.54 − − − − 0.54
L2 0.52 − − − − −
All 0.41 0.42 0.43 0.45 0.46 0.52
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